Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA
Guofang Chen, Binya Liu, Shasha Yin, et al.
Oncogenesis (2020) Vol. 9, Iss. 9
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

The role of m6A RNA methylation in cancer metabolism
Yuanyuan An, Hua Duan
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 476
The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 179
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
Jianwei Qu, Haimeng Yan, Yifan Hou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 145
FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis
Dan‐Yun Ruan, Ting Li, Yingnan Wang, et al.
Oncogene (2021) Vol. 40, Iss. 33, pp. 5168-5181
Open Access | Times Cited: 117
m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy
Kousalya Lavudi, Shreya Madhav Nuguri, Prashant Pandey, et al.
Life Sciences (2024) Vol. 356, pp. 123033-123033
Closed Access | Times Cited: 16
Synonymous mutations promote tumorigenesis by disrupting m6A-dependent mRNA metabolism
Yiheng Lan, Zhen Xia, Qizhe Shao, et al.
Cell (2025)
Closed Access | Times Cited: 2
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
The involvement of RNA N6‐methyladenosine and histone methylation modification in decidualization and endometriosis‐associated infertility
Xiang Lin, Yongdong Dai, Weijia Gu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 11
Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health
Peipei Li, Yumeng Lin, Hongyun Ma, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
Constanze Banz‐Jansen, Laureen P. Helweg, Barbara Kaltschmidt
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3412-3412
Open Access | Times Cited: 32
Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer
Egle-Helene Ervin, Rhiannon French, Chao‐Hui Chang, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 48-83
Open Access | Times Cited: 31
N6‐methyladenosine (m6A) modification in gynecological malignancies
Chunmei Zhang, Ning Liu
Journal of Cellular Physiology (2022) Vol. 237, Iss. 9, pp. 3465-3479
Closed Access | Times Cited: 30
Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 30
Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment
Ángela Patricia Moreno-Londoño, Martha Robles‐Flores
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 25-51
Open Access | Times Cited: 20
New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy
Lidan Zeng, Yueming Zhu, Carlos S. Moreno, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 29-44
Open Access | Times Cited: 19
Glucose Transporter 1-Mediated Transcytosis of Glucosamine-Labeled Liposomal Ceramide Targets Hypoxia Niches and Cancer Stem Cells to Enhance Therapeutic Efficacy
Lu-Yi Yu, Pei‐Wei Shueng, Hsin‐Cheng Chiu, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13158-13175
Closed Access | Times Cited: 17
Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting
Qianqian Guo, Yi Zhou, Tianyuan Xie, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101043-101043
Open Access | Times Cited: 17
Dynamic RNA methylation modifications and their regulatory role in mammalian development and diseases
Wenlan Yang, Yongliang Zhao, Yun‐Gui Yang
Science China Life Sciences (2024)
Closed Access | Times Cited: 8
Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
Xuan Han, Yu Zhu, Juan Ke, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Regulation of Embryonic Stem Cell Self-Renewal
Guofang Chen, Shasha Yin, Hongliang Zeng, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1151-1151
Open Access | Times Cited: 25
m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation
Yuan Gao, Miao Yu, Zengyuan Liu, et al.
Translational Oncology (2024) Vol. 41, pp. 101858-101858
Open Access | Times Cited: 5
Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
RNA N6‐methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential
Zhihui Zhang, Chaoqi Zhang, Yuejun Luo, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 9
Open Access | Times Cited: 29
Weaponizing natural killer cells for solid cancer immunotherapy
Joshua K.M. Wong, Riccardo Dolcetti, Handoo Rhee, et al.
Trends in cancer (2022) Vol. 9, Iss. 2, pp. 111-121
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top